VETMEDIN 1.25 MG FLAVOUR TABLETS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
15-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PIMOBENDAN
Available from:
Boehringer Ingelheim Ltd
ATC code:
QC01CE90
Dosage:
1.25 Milligram
Pharmaceutical form:
Tablets
Therapeutic group:
Cardiovascular
Therapeutic area:
Canine
Authorization date:
2006-06-09
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetmedin 1.25 mg Flavour Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Pimobendan
1.25 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablets.
Meat flavoured, oval scored mottled brown tablets with fine white spots.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid
regurgitation) or dilated cardiomyopathy.
When used in cases of valvular insufficiency in conjunction with furosemide, the product has been shown to improve
the quality of life and extend life expectancy in treated dogs.
When used in a limited number of cases of dilated cardiomyopathy in large breed dogs in conjunction with concomitant
standard therapy, the product has been shown to improve the quality of life and to extend life expectancy in treated
dogs.
4.3 CONTRAINDICATIONS
The veterinary medicinal product should not be used in cases of hypertrophic cardiomyopathies or clinical conditions
where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic stenosis).
See also section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 08/04/2011_
_CRN 7009844_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of accidental inge
Read the complete document
